These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38832144)

  • 1. Safety and Effectiveness of Intravitreal Brolucizumab Injection in Combination With Sub-Tenon's Capsule Triamcinolone Acetonide Injection for Polypoidal Choroidal Vasculopathy During the Loading Phase.
    Yoshikawa Y; Sakaki Y; Shinoda K; Kataoka K
    Cureus; 2024 May; 16(5):e59481. PubMed ID: 38832144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
    Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD
    Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sub-Tenon's capsule triamcinolone acetonide injection to prevent brolucizumab-associated intraocular inflammation.
    Hikichi T
    Graefes Arch Clin Exp Ophthalmol; 2022 Aug; 260(8):2529-2535. PubMed ID: 35235038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal Brolucizumab and Aflibercept for Polypoidal Choroidal Vasculopathy.
    Cho HJ; Kang KH; Yoon W; Lee J; Kim CG; Kim JW
    J Ocul Pharmacol Ther; 2023 Nov; 39(9):653-660. PubMed ID: 37504966
    [No Abstract]   [Full Text] [Related]  

  • 5. A case of intraocular inflammation after intravitreal brolucizumab injection monitored by laser flare-cell photometer.
    Saito M; Kobori H; Nozuki N; Kogawa S; Kudo A
    Am J Ophthalmol Case Rep; 2022 Dec; 28():101727. PubMed ID: 36281264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term outcomes of intravitreal brolucizumab for treatment-naïve neovascular age-related macular degeneration with type 1 choroidal neovascularization including polypoidal choroidal vasculopathy.
    Matsumoto H; Hoshino J; Mukai R; Nakamura K; Akiyama H
    Sci Rep; 2021 Mar; 11(1):6759. PubMed ID: 33762600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sub-Tenon's injection of triamcinolone acetonide for choroidal neovascularization].
    Kim A; Gomi F; Sakaguchi H; Oshima Y; Ikuno Y; Kamei M; Oji M; Tano Y
    Nippon Ganka Gakkai Zasshi; 2006 Jan; 110(1):19-24. PubMed ID: 16491869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Intravitreal Brolucizumab in the Treatment of Polypoidal Choroidal Vasculopathy With Foveal Lipid Exudation.
    Carta V; Lixi F; Tatti F; Peiretti E
    Cureus; 2023 Oct; 15(10):e47942. PubMed ID: 38034243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of intravitreal preservative-free triamcinolone versus posterior sub-tenon triamcinolone acetonide injection for bevacizumab-resistant diabetic macular edema.
    Jeon SH; Kim M; Roh YJ
    BMC Ophthalmol; 2024 Jan; 24(1):25. PubMed ID: 38243166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switching to brolucizumab from aflibercept in age-related macular degeneration with type 1 macular neovascularization and polypoidal choroidal vasculopathy: an 18-month follow-up study.
    Ueda-Consolvo T; Tanigichi A; Numata A; Oiwake T; Nakamura T; Ishida M; Yanagisawa S; Hayashi A
    Graefes Arch Clin Exp Ophthalmol; 2023 Feb; 261(2):345-352. PubMed ID: 35947181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Outcomes between 3 Monthly Brolucizumab and Aflibercept Injections for Polypoidal Choroidal Vasculopathy.
    Fukuda Y; Sakurada Y; Matsubara M; Hasebe Y; Sugiyama A; Kikushima W; Kashiwagi K
    Biomedicines; 2021 Sep; 9(9):. PubMed ID: 34572350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-year outcomes of intravitreal brolucizumab injections in patients with polypoidal choroidal vasculopathy.
    Ito A; Maruyama-Inoue M; Kitajima Y; Ikeda S; Inoue T; Kadonosono K
    Sci Rep; 2022 May; 12(1):7987. PubMed ID: 35568780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of brolucizumab versus aflibercept in eyes with polypoidal choroidal vasculopathy in Japanese participants of HAWK.
    Ogura Y; Jaffe GJ; Cheung CMG; Kokame GT; Iida T; Takahashi K; Lee WK; Chang AA; Monés J; D'Souza D; Weissgerber G; Gedif K; Koh A
    Br J Ophthalmol; 2022 Jul; 106(7):994-999. PubMed ID: 34301613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visual improvement following trans-Tenon's retrobulbar triamcinolone acetonide infusion for polypoidal choroidal vasculopathy.
    Okubo A; Ito M; Kamisasanuki T; Sakamoto T
    Graefes Arch Clin Exp Ophthalmol; 2005 Aug; 243(8):837-9. PubMed ID: 15761763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of one-year outcomes between as-needed brolucizumab and aflibercept for polypoidal choroidal vasculopathy.
    Fukuda Y; Sakurada Y; Matsubara M; Kotoda Y; Kasai Y; Sugiyama A; Kashiwagi K
    Jpn J Ophthalmol; 2023 Jul; 67(4):402-409. PubMed ID: 37289296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial experience in treating polypoidal choroidal vasculopathy with brolucizumab in Indian eyes - A multicenter retrospective study.
    Chakraborty D; Maiti A; Sengupta S; Mondal S; Nandi K; Chakraborty S
    Indian J Ophthalmol; 2022 Apr; 70(4):1295-1299. PubMed ID: 35326038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-year results of treat-and-extend regimen with intravitreal brolucizumab for treatment-naïve neovascular age-related macular degeneration with type 1 macular neovascularization.
    Matsumoto H; Hoshino J; Mukai R; Nakamura K; Akiyama H
    Sci Rep; 2022 May; 12(1):8195. PubMed ID: 35581196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to brolucizumab treatment for refractory serous pigment epithelial detachment secondary to polypoidal choroidal vasculopathy.
    Nam SW; Byun Z; Ham DI; Kong M
    BMC Ophthalmol; 2022 Dec; 22(1):485. PubMed ID: 36514022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three Japanese cases of intraocular inflammation after intravitreal brolucizumab injections in one clinic.
    Hikichi T
    Jpn J Ophthalmol; 2021 Mar; 65(2):208-214. PubMed ID: 33543351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of sub-Tenon's capsule triamcinolone acetonide injection combined with microaneurysm photocoagulation on diabetic macular edema.
    Oshitari T; Nonomura S; Arai M; Takatsuna Y; Sato E; Baba T; Yamamoto S
    Int Med Case Rep J; 2015; 8():321-6. PubMed ID: 26675141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.